Activins, members of the TGF-beta superfamily, are disulfide-linked dimeric proteins originally purified from gonadal fluids as proteins that stimulated pituitary follicle stimulating hormone (FSH) release. Activin proteins have a wide range of biological activities, including mesoderm induction, neural cell differentiation, bone remodeling, hematopoiesis and roles in reproductive physiology. Activin isoforms and other members of the TGF-beta superfamily exert their biological effects by binding to heteromeric complexes of a type I and a type II serine-threonine kinase receptor, both of which are essential for signal transduction.
North Americas is the largest consumption place, with a revenue market share nearly 51.4% in 2018. Following North America, Europe is the second largest consumption place with the revenue market share of 29.4% in 2018. The classification of Activin A includes Activin A Human, Activin-A Mouse/Rat. The sales proportion of Activin A Human in 2018 is about 81.85%, and the revenue proportion of Activin-A Mouse/Rat in 2018 is about 18.15%. Activin A is application for Commercial Research and Academic Research. The most of Activin A is used in Commercial Research, and the market share in 2018 is about 71.96%.

The global Activin A market is valued at 11 million US$ in 2020 is expected to reach 26 million US$ by the end of 2026, growing at a CAGR of 12.5% during 2021-2026.
This report focuses on Activin A volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Activin A market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan and Middle East & Africa etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Activin A market is segmented into
Activin A Human
Activin-A Mouse/Rat
Activin A Human is the largest segment with a market share of 81.85% in 2018.

Segment by Application
Commercial Research
Academic Research
The largest application is commercial research, which accounted for 72.14% in 2018.

Global Activin A Market: Regional Analysis
The Activin A market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Activin A market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global Activin A Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Activin A market include:
Merck Millipore
Thermo Fisher Scientific
Bio-Techne
StemRD
Prospec
Proteintech Group
Ajinomoto
Enzo Life Sciences
IBL
STEMCELL
Sino Biological
PeproTech
ReproCELL